-- Dr. Reddy's, Reliance, Ashoka, Bedmutha, Uflex Ltd.: India Stocks Preview
-- B y   R a j h k u m a r   K   S h a a w
-- 2010-10-14T03:00:47Z
-- http://www.bloomberg.com/news/2010-10-14/dr-reddy-s-reliance-ashoka-bedmutha-uflex-ltd-india-stocks-preview.html
The following companies may have
 unusual  price changes in India  trading . Stock symbols are in
parentheses and share prices are as of the  last close .  The Bombay Stock Exchange’s Sensitive Index, or  Sensex ,
gained 484.54, or 2.4 percent, to 20,687.88. The S&P CNX  Nifty 
Index on the National Stock Exchange rose 2.4 percent to
6,233.90. The  BSE 200 Index  increased 2 percent to 2,623.94.  SGX
S&P CNX Nifty Index futures  for October delivery climbed 0.2
percent to 6,290 as of 10:23 a.m. in Singapore.  Ashoka Buildcon Ltd.  (ASBL IN): The roads developer will
make its trading debut on the bourses today. The company, based
in Nashik, Maharashtra, received bids for 98.9 million shares
compared with 6.22 million shares offered in the sale last
month.  Bedmutha Industries Ltd.  (BEDM IN): The steel wire
manufacturer will make its trading debut today. The company
raised 918 million rupees ($20.6 million) selling 42.8 percent
of its shares in a sale that was completed on Oct. 1  Cairn India Ltd.  (CAIR IN): The Indian government has asked
Cairn Energy Plc to resolve taxation, royalty and oil-field
management matters concerning the country’s largest oil field in
Rajasthan before it seeks approval to sell a controlling stake
in Cairn India Ltd. to Vedanta Resources Plc, the Economic Times
of India reported. Cairn India added 0.4 percent to 342.7
rupees.  Dr. Reddy’s Laboratories Ltd.  (DRRD IN): The drugmaker had
its stock rating raised to “buy” from “underperform” by S.
Arun, an analyst at Bank of America-Merrill Lynch, who cited
increased “business visibility.” The stock rose 1.1 percent to
1,587.1 rupees.       GlaxoSmithKline Pharmaceuticals Ltd.  (GLXO IN):
 GlaxoSmithKline Plc  Chief Executive Officer  Andrew Witty  said
the company’s experimental malaria vaccine is showing promise
and that results from final clinical trials should be available
as soon as next year. GlaxoSmithKline Pharmaceuticals, the local
unit, increased 0.3 percent to 2,295.05 rupees.  Reliance Industries Ltd.  (RIL IN): India’s most valuable
company started marketing its sale of bonds denominated in U.S.
dollars, according to a person familiar with the matter. The
stock increased 1.7 percent to 1,073.05 rupees.  Uflex Ltd.  (UFLX IN): The maker of plastic packaging
materials has withdrawn its rights offer. The shares gained 10
percent to 290 rupees.  To contact the reporter on this story:
 Rajhkumar K Shaaw  in Mumbai at 
 rshaaw@bloomberg.net .  To contact the editor responsible for this story:
Reinie Booysen at   rbooysen@bloomberg.net  